SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company that manufactures, markets and sells ArteFill®, the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or “smile line” wrinkles, today announced the publication of data comparing polymethylmethacrylate (PMMA) based soft tissue fillers in the June Filler Issue of Dermatologic Surgery, a peer-reviewed publication of the American Society for Dermatologic Surgery. The study, sponsored by Artes Medical, is available at http://delivery.sheridan.com/index.php?ID=blk/BLK_139025_CP.
